H-1B Filings
25
Major sponsor. DOL labor condition applications on file.
AbbVie Biotherapeutics Inc. in IL (Manufacturing) is dominated by DOL H-1B labor-condition applications (25 on file) at a $146,000 disclosed median; OSHA and WARN tracks are empty here.
AbbVie Biotherapeutics Inc. (IL): · 25 H-1B LCAs at a $146,000 disclosed median
According to DOL OFLC H-1B disclosures, OSHA ITA injury logs, and state WARN Act notices, AbbVie Biotherapeutics Inc. in IL carries 25 H-1B wage filings on record, a $146,000 median wage (above the $124,488 national median) and no WARN layoff notices on file. Every figure is a federal filing, not an estimate; see methodology for coverage limits.
The record at a glance
Compared with the rest of PlainEmployers' federal employer corpus, H-1B filing volume ranks #2,002 of 51,370 sponsors in this corpus (about the 96th percentile), and disclosed median wage sits at the 66th percentile of 272,125 credible H-1B wage rows.
Figures above come from DOL H-1B labor condition applications only, OSHA and WARN tracks are empty on this profile.
A weighted composite of DOL H-1B sponsorship and pay, OSHA establishment injury records, and WARN Act layoff notices, not culture, benefits, or "is this a good place to work." Missing tracks drop out and their weight redistributes so sparse records are not silently deflated.
Weights (redistributed when a track is N/A): Sponsorship scale (H-1B volume) 15% · Disclosed pay (H-1B wage percentile) 25% · Workplace safety (OSHA DART percentile) 35% · Layoff stability (WARN percentile) 25%. Sources: DOL OFLC · OSHA ITA · state WARN filings.
DOL LCA release change
H-1B Filings
25
Major sponsor. DOL labor condition applications on file.
Median H-1B Salary
$146,000
Above national median. Across 25 disclosed positions
Where AbbVie Biotherapeutics Inc.'s H-1B wage sits nationally
Median disclosed wage vs. all US employers with H-1B filings
$146,000 Top 34% higher than 66% of 272,125 US employers
Each bar is a $20K-wide band; taller bars hold more US employers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source DOL Office of Foreign Labor Certification, H-1B Disclosure Data · August 2026
Filing-count-weighted median across this employer's own disclosed H-1B positions (-6.1% year over year), not a company-wide raise, and not adjusted for role mix changes between years.
| Field | Value | Source |
|---|---|---|
| Employer Name | AbbVie Biotherapeutics Inc. | DOL OFLC |
| Industry | Manufacturing | NAICS / DOL |
| State | IL | U.S. Federal Records |
| H-1B Filings | 25 | DOL OFLC LCA Disclosure |
| H-1B Median Salary | $146,000 | DOL OFLC LCA Disclosure |
| Tracks not on file | employer OSHA injury log, WARN notices | Empty by design, not estimated |
AbbVie Biotherapeutics Inc.'s values above reflect the most recent DOL Labor Condition Applications on file for this employer in IL (Manufacturing). In this corpus, H-1B filing volume ranks #2,002 of 51,370 sponsors in this corpus (about the 96th percentile); disclosed median wage sits at the 66th percentile of 272,125 credible H-1B wage rows; WARN history is cleaner than 14% of 304,376 employers tracked here.
| Job Title | Median |
|---|---|
| DIRECTOR, R&D STRATEGIC PRIORITIES | $226,000 |
| ASSOCIATE DIRECTOR, CMC PROGRAM STRATEGY | $219,000 |
| ASSOCIATE DIRECTOR REGULATORY AFFAIRS, CMC | $200,000 |
| ASSOCIATE DIRECTOR, REGULATORY AFFAIRS CMC | $200,000 |
| SR. MANAGER RA, GLOBAL REG STRATEGY US & CANADA | $178,000 |
| PRINCIPAL RESEARCH SCIENTIST I | $177,000 |
| PRINCIPAL SCIENTIST I, IN VIVO PHARMACOLOGY | $177,000 |
| MANAGER, IT | $173,000 |
| PRINCIPAL RESEARCH SCIENTIST | $167,000 |
| MANAGER, STATISTICAL PROGRAMMING | $165,000 |
| Senior Scientist I, Chemistry | $152,847 |
| Senior Scientist, DMPK | $146,758 |
| SR. SCIENTIST I | $146,000 |
| SENIOR BUSINESS SYSTEMS ANALYST | $143,000 |
| SR. SCIENTIST I | $141,000 |
| SENIOR SCIENTIST II | $140,000 |
| Senior Scientist I, Cell Line Development | $140,000 |
| SENIOR SCIENTIST I | $139,000 |
| SCIENTIST II | $135,000 |
| Scientist, Cell/Molecular Biology | $121,264 |
| SCIENTIST I | $120,000 |
| SCIENTIST I | $117,000 |
| Scientist II | $115,000 |
| Analyst, Procure To Pay Service | $107,643 |
| Associate Scientist II, Bioinformatics Analyst | $92,319 |
AbbVie Biotherapeutics Inc.'s most extreme placement is sponsorship scale: 25 H-1B LCAs rank higher than 96% of sponsors in this corpus (#2,002 of 51,370).
FY2025 filings fell 62.5% from FY2024 (16 → 6).
AbbVie Biotherapeutics Inc. sponsors 25 H-1B positions but carries no employer OSHA DART rate here — at this filing volume the gap usually reflects recordkeeping exemptions, not a verified safety judgment.
No WARN Act mass-layoff notices are on file for AbbVie Biotherapeutics Inc. among Manufacturing employers we track.
A $146,000 disclosed median lands near the middle of the wage distribution (66th percentile vs $124,488 nationally).
Disclosed medians moved from $153,104 (FY2024) to $143,694 (FY2025) (-6.1%), weighted by this employer's own LCA rows — not a company-wide raise and not role-mix adjusted.
Where AbbVie Biotherapeutics Inc. sits
Across the 200 Manufacturing sponsors in this corpus with both an H-1B filing count and a credible disclosed-wage median, AbbVie Biotherapeutics Inc. files more petitions than 19% of them and discloses a higher median wage than 59%, the selective, above-median pay quadrant. Filing volume is hiring scale, not pay; the axes are independent DOL OFLC disclosures (25 filings · $146,000 median here).
Each muted dot is one manufacturing peer from a filings-stratified sample of 41; the brand marker is AbbVie Biotherapeutics Inc.. Source: DOL Office of Foreign Labor Certification H-1B LCA disclosures (credible wages recomputed from per-position filings, excluding parse errors above $500k).
AbbVie Biotherapeutics Inc.'s nearest H-1B-filing peers in Manufacturing (home state IL). Each card links to that employer's federal-records profile.
What to check before working with AbbVie Biotherapeutics Inc.
For AbbVie Biotherapeutics Inc., start with sponsorship pay (25 H-1B LCAs, median $146,000) and only then layer any other federal silence.
AbbVie Biotherapeutics Inc.'s figures are legally filed public records (DOL, OSHA, state WARN), not reviews or vendor estimates; a missing row is not proof the underlying activity never happened.
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from OSHA and the DOL Wage and Hour Division. Consult a qualified professional before making decisions based on this data.
Among 272,125 credible H-1B wage rows in this corpus, AbbVie Biotherapeutics Inc.'s disclosed median of $146,000 sits at the 66th percentile (above the $124,488 national median). The chart above uses a COUNT-exact percentile (rows below this wage ÷ total), not an interpolated estimate.
AbbVie Biotherapeutics Inc. has 25 H-1B filings on record, ranking #2,002 of 51,370 sponsors in this corpus (about the 96th percentile by volume). Filing volume is a sponsorship signal, not a headcount or hiring-quality score.
Related guides: How OSHA safety grades are calculated · Using H-1B wage filings in salary negotiation
Read our methodology - how this data is sourced, computed, and verified.
This profile is rendered directly from DOL H-1B disclosure filings, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.